<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S1327 IS: SALTS Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-05-13</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>114th CONGRESS</congress><session>1st Session</session><legis-num>S. 1327</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20150513">May 13, 2015</action-date><action-desc><sponsor name-id="S311">Ms. Klobuchar</sponsor> (for herself, <cosponsor name-id="S293">Mr. Graham</cosponsor>, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, and <cosponsor name-id="S153">Mr. Grassley</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSJU00">Committee on the Judiciary</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend the Controlled Substances Act relating to controlled substance analogues. </official-title></form>
	<legis-body>
 <section id="id181A23D686AF469DBE0E5BEEA0422D6E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Synthetic Abuse and Labeling of Toxic Substances Act of 2015</short-title></quote> or the <quote>SALTS Act</quote>.</text>
		</section><section id="id10D114B5ACA94FE1B7145CB2EE1B864C" section-type="subsequent-section"><enum>2.</enum><header>Controlled substance
 analogues</header><text display-inline="no-display-inline">Section 203 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/813">21 U.S.C. 813</external-xref>) is amended—</text>
 <paragraph id="id2A6C6D2757144DD3B6FA4159E53942CA"><enum>(1)</enum><text>by striking <quote>A controlled</quote> and inserting <quote>(a) <header-in-text level="subsection" style="OLC">In general</header-in-text>.—A controlled</quote>; and</text>
 </paragraph><paragraph id="id03199480C98F43B5A6429DC8A3B1FBBB"><enum>(2)</enum><text>by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="id80EE26A65B8B4244AE732977A2E3795C" style="OLC">
 <subsection id="idA13896C2F54E438F9E8F16A47E87D02F"><enum>(b)</enum><header>Determination</header><text>In determining whether a controlled substance analogue was intended for human consumption under subsection (a), evidence related to the following factors may be considered, along with all other relevant evidence:</text>
 <paragraph id="id74813ba469d84b8eacb1f15381b7de05"><enum>(1)</enum><text>The marketing, advertising, and labeling of the substance.</text>
 </paragraph><paragraph id="ide3d777d52ab64a8c9dfa428703a44c4c"><enum>(2)</enum><text>The known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose.</text>
 </paragraph><paragraph id="id37ff210446df4ab78868aa35776109e0"><enum>(3)</enum><text>The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.</text>
 </paragraph><paragraph id="id6da3061a85ad4bb4bcd4054a26665e1f"><enum>(4)</enum><text>The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.</text>
 </paragraph><paragraph id="id7d2e30f28d734fe29389380fa4ec4c10"><enum>(5)</enum><text>Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.</text>
 </paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ida59a47467e5d416bb89f39995dc2bb2c"><enum>(c)</enum><header>Limitation</header><text>For purposes of this section, the existence of evidence that a substance was not marketed, advertised, or labeled for human consumption shall not preclude the Government from establishing, based on all the evidence, that the substance was intended for human consumption.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill>


